Table 1.
Selected Baseline Characteristics of Study Participants Overall and by AF Status During Follow‐up, Multi‐Ethnic Study of Atherosclerosis
| Overall (N=6663) | No AF (N=6312) | AF (N=351) | |
|---|---|---|---|
| Age, y | 62 (10) | 62 (10) | 69 (8) |
| Women, N (%) | 3517 (53) | 3369 (53) | 148 (42) |
| Race/ethnicity, N (%) | |||
| Non‐Hispanic white | 2559 (38) | 2372 (38) | 187 (53) |
| Non‐Hispanic African American | 1835 (28) | 1763 (28) | 72 (21) |
| Hispanic | 1477 (22) | 1412 (22) | 65 (19) |
| Chinese American | 792 (12) | 765 (12) | 27 (8) |
| Height, cm | 166 (10) | 166 (10) | 168 (11) |
| Weight, kg | 79 (17) | 78 (17) | 82 (18) |
| Systolic BP, mm Hg | 126 (21) | 126 (21) | 135 (23) |
| Diastolic BP, mm Hg | 72 (10) | 72 (10) | 72 (11) |
| Current smoking, N (%) | 870 (13) | 833 (13) | 37 (11) |
| Use of antihypertensive medication, N (%) | 2457 (37) | 2270 (36) | 187 (53) |
| Diabetes, N (%) | 833 (13) | 777 (12) | 56 (16) |
| PR interval, ms | 166 (25) | 165 (24) | 173 (32) |
| NT‐proBNP, pg/mL | 101 (249) | 93 (225) | 247 (491) |
| hsCRP, mg/L | 3.8 (5.9) | 3.8 (5.9) | 3.9 (5.7) |
Values correspond to mean (SD) or N (%).AF indicates atrial fibrillation; BP, blood pressure; hsCRP, high‐sensitivity C‐reactive protein; NT‐proBNP, N‐terminal of the prohormone B‐type natriuretic peptide.